Alan Ezekowitz insider trades: Fulcrum Therapeutics (FULC) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Alan reports to the SEC
Open-market buys and sales
3 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jun 26, 2026 | FULC | ↓ Sell | 18,000 | $3.65 | $66K | Direct | Jun 30, 2026 (4d) |
| Mar 7, 2025 | SEPN | ↑ Buy | 13,319 | $6.93 | $92K | Direct | Mar 10, 2025 (3d) |
| Mar 6, 2025 | SEPN | ↑ Buy | 86,681 | $5.95 | $516K | Direct | Mar 6, 2025 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other FULC insiders
Open-market trades in the last 12 months
About Alan Ezekowitz's insider trades
Alan Ezekowitz is an insider at Fulcrum Therapeutics (FULC). Since Mar 6, 2025, Alan has reported 2 open-market purchases worth $608K and 1 sale worth $66K on SEC Form 4. In the last 12 months: 1 sale ($66K).
Their filings also include grants and awards (17 filings), other transactions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every FULC insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.